EP3421493 - MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 15.12.2023 Database last updated on 31.08.2024 | |
Former | Grant of patent is intended Status updated on 16.08.2023 | ||
Former | Examination is in progress Status updated on 30.03.2020 | ||
Former | Request for examination was made Status updated on 05.07.2019 | ||
Former | The application has been published Status updated on 30.11.2018 | Most recent event Tooltip | 19.07.2024 | Lapse of the patent in a contracting state New state(s): HR, RS | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Progastrine et Cancers S.à r.l. 11, Côte d'Eich 1450 Luxembourg / LU | For all designated states CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 3, rue Michel Ange 75016 Paris / FR | For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75013 Paris / FR | [2019/01] | Inventor(s) | 01 /
PANNEQUIN, Julie 13 rue Henri Barbusse 34200 Sète / FR | 02 /
BOUDIER, Laure Batiment 0, Appartment 69 Residence "Les Jardins du Pere Soulas" 76 Rue de St Priest 34090 Montpellier / FR | 03 /
JOUBERT, Dominique 10 rue Gabriel Péri 34200 Sète / FR | 04 /
HOLLANDE, Frédéric 63 chemin de la Deridiere 34270 Les Matelles / FR | [2019/01] | Representative(s) | Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [2019/01] | Application number, filing date | 18185172.6 | 15.10.2010 | [2019/01] | Priority number, date | US200925262509P | 16.10.2009 Original published format: US 25262509 P | [2019/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3421493 | Date: | 02.01.2019 | Language: | EN | [2019/01] | Type: | B1 Patent specification | No.: | EP3421493 | Date: | 17.01.2024 | Language: | EN | [2024/03] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.11.2018 | Classification | IPC: | C07K16/26, A61K39/395, A61P35/00 | [2019/01] | CPC: |
C07K16/26 (EP,IL,KR,US);
A61K39/395 (IL);
A61P1/00 (EP);
A61P35/00 (EP,IL);
G01N33/57419 (IL,US);
G01N33/57488 (IL,US);
A61K2039/505 (EP,IL,US);
C07K2317/24 (EP,US);
C07K2317/33 (EP,IL,US);
C07K2317/34 (EP,US);
C07K2317/565 (EP,US);
C07K2317/567 (EP,US);
C07K2317/73 (EP,IL,US);
C07K2317/76 (US);
C07K2317/92 (EP,IL,US);
G01N2333/595 (IL,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/32]
![]() |
Former [2019/01] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 01.07.2019 | ME | 01.07.2019 | Title | German: | MONOKLONALE ANTIKÖRPER GEGEN PROGASTRIN UND VERWENDUNGEN DAVON | [2019/01] | English: | MONOCLONAL ANTIBODIES TO PROGASTRIN AND THEIR USES | [2019/01] | French: | ANTICORPS MONOCLONAUX CONTRE LA PROGASTRINE ET LEURS UTILISATIONS | [2019/01] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 01.07.2019 | Amendment by applicant (claims and/or description) | 01.07.2019 | Examination requested [2019/32] | 01.07.2019 | Date on which the examining division has become responsible | 02.04.2020 | Despatch of a communication from the examining division (Time limit: M06) | 07.10.2020 | Reply to a communication from the examining division | 21.04.2021 | Despatch of a communication from the examining division (Time limit: M04) | 30.08.2021 | Reply to a communication from the examining division | 29.06.2023 | Cancellation of oral proceeding that was planned for 05.07.2023 | 05.07.2023 | Date of oral proceedings (cancelled) | 17.08.2023 | Communication of intention to grant the patent | 13.12.2023 | Fee for grant paid | 13.12.2023 | Fee for publishing/printing paid | 13.12.2023 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP10768878.0 / EP2488551 | Fees paid | Renewal fee | 24.07.2018 | Renewal fee patent year 03 | 24.07.2018 | Renewal fee patent year 04 | 24.07.2018 | Renewal fee patent year 05 | 24.07.2018 | Renewal fee patent year 06 | 24.07.2018 | Renewal fee patent year 07 | 24.07.2018 | Renewal fee patent year 08 | 10.10.2018 | Renewal fee patent year 09 | 08.10.2019 | Renewal fee patent year 10 | 13.10.2020 | Renewal fee patent year 11 | 26.10.2021 | Renewal fee patent year 12 | 27.09.2022 | Renewal fee patent year 13 | 13.09.2023 | Renewal fee patent year 14 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HR | 17.01.2024 | RS | 17.04.2024 | IS | 17.05.2024 | [2024/34] |
Former [2024/32] | IS | 17.05.2024 | Documents cited: | Search | [XY]WO2006032980 (APHTON CORP [US], et al); | [XY]WO2007135542 (INST NAT SANTE RECH MED [FR], et al); | [A]WO2008076454 (UNIV TEXAS [US]); | by applicant | US4399216 | US4510245 | US4634665 | EP0239400 | US4737456 | US4816567 | US4816397 | US4968615 | WO9109967 | WO9110741 | US5168062 | EP0519596 | US5179017 | US5219996 | WO9312227 | US5225539 | EP0592106 | US5530101 | US5545806 | US5565332 | US5585089 | US5658570 | US5681722 | US5693761 | US5693762 | US5693780 | US5807715 | EP0948544 | US6150584 | US6180370 | WO2007135542 | WO2008076454 |